Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction

Area of Science:

• Molecular biology
• Virology
• Biophysics

Background:

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic poses a significant global health threat.
• Viral entry into host cells is mediated by the interaction between the SARS-CoV-2 spike protein's receptor-binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor.
• Understanding this interaction is crucial for developing effective countermeasures.

Purpose of the Study:

• To investigate the molecular dynamics of the SARS-CoV-2 RBD-ACE2 interaction.
• To compare the binding characteristics of SARS-CoV-2 RBD with that of the related SARS-CoV RBD.
• To identify key residues contributing to differential binding affinities.

Main Methods:

• Microsecond molecular dynamics simulations of the RBD-ACE2 complex for both SARS-CoV-2 and SARS-CoV.
• Analysis of binding kinetics and interfacial residue dynamics.
• Validation across multiple simulation timescales and force fields.

Main Results:

• Mutated residues in SARS-CoV-2 RBD significantly enhance binding affinity to ACE2 compared to SARS-CoV.
• SARS-CoV-2 RBD exhibits a reduced dissociation rate from ACE2, indicating a stronger, more stable interaction.
• These binding differences were consistently observed in simulations exceeding 500 ns and across different computational models.

Conclusions:

• The study elucidates the critical role of specific RBD mutations in SARS-CoV-2's enhanced binding to human ACE2.
• The findings provide molecular insights into the increased transmissibility of SARS-CoV-2.
• This research can inform the design of targeted diagnostics and therapeutics against SARS-CoV-2.